Literature DB >> 23020644

Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.

Caroline Mitchell1, Jennifer E Balkus, David Fredricks, Congzhou Liu, Jennifer McKernan-Mullin, Lisa M Frenkel, Christina Mwachari, Amneris Luque, Susan E Cohn, Craig R Cohen, Robert Coombs, Jane Hitti.   

Abstract

Bacterial vaginosis has been associated with genital HIV-1 shedding; however, the effect of specific vaginal bacterial species has not been assessed. We tested cervicovaginal lavage from HIV-1-seropositive women for common Lactobacillus species: L. crispatus, L. jensenii, and seven BV-associated species: BVAB1, BVAB2, BVAB3, Leptotrichia, Sneathia, Megasphaera, and Atopobium spp. using quantitative PCR. We used linear and Poisson regression to evaluate associations between vaginal bacteria and genital HIV-1 RNA and DNA. Specimens from 54 U.S. (310 visits) and 50 Kenyan women (137 visits) were evaluated. Controlling for plasma viral load, U.S. and Kenyan women had similar rates of HIV-1 RNA (19% of visits vs. 24%; IRR=0.95; 95% CI 0.61, 1.49) and DNA shedding (79% vs. 76%; IRR=0.90; 0.78, 1.05). At visits during antiretroviral therapy (ART), the likelihood of detection of HIV-1 RNA shedding was greater with BVAB3 (IRR=3.16; 95% CI 1.36, 7.32), Leptotrichia, or Sneathia (IRR=2.13; 1.02, 4.72), and less with L. jensenii (IRR=0.39; 0.18, 0.84). At visits without ART, only L. crispatus was associated with a lower likelihood of HIV-1 RNA detection (IRR=0.6; 0.40, 0.91). Vaginal Lactobacillus species were associated with lower risk of genital HIV-1 shedding, while the presence of certain BV-associated species may increase that risk.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020644      PMCID: PMC3537306          DOI: 10.1089/AID.2012.0187

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  40 in total

1.  Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial.

Authors:  Mark H Yudin; Daniel V Landers; Leslie Meyn; Sharon L Hillier
Journal:  Obstet Gynecol       Date:  2003-09       Impact factor: 7.661

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

Authors:  Susan M Graham; Sarah E Holte; Norbert M Peshu; Barbra A Richardson; Dana D Panteleeff; Walter G Jaoko; Jeckoniah O Ndinya-Achola; Kishorchandra N Mandaliya; Julie M Overbaugh; R Scott McClelland
Journal:  AIDS       Date:  2007-02-19       Impact factor: 4.177

4.  Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.

Authors:  Beverly E Sha; M Reza Zariffard; Qiong J Wang; Hua Y Chen; James Bremer; Mardge H Cohen; Gregory T Spear
Journal:  J Infect Dis       Date:  2004-12-02       Impact factor: 5.226

5.  Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load.

Authors:  James E Cummins; Logan Christensen; Jeffery L Lennox; Timothy J Bush; Zhiwei Wu; Daniel Malamud; Tammy Evans-Strickfaden; Aladin Siddig; Angela M Caliendo; Clyde E Hart; Charlene S Dezzutti
Journal:  AIDS Res Hum Retroviruses       Date:  2006-08       Impact factor: 2.205

6.  Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.

Authors:  Samuel A Williams; Hakju Kwon; Lin-Feng Chen; Warner C Greene
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Coamplification of HIV type 1 and beta-globin gene DNA sequences in a nonisotopic polymerase chain reaction assay to control for amplification efficiency.

Authors:  F Coutlée; Y He; P Saint-Antoine; C Olivier; A Kessous
Journal:  AIDS Res Hum Retroviruses       Date:  1995-03       Impact factor: 2.205

8.  Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay.

Authors:  Lawrence Corey; Meei-Li Huang; Stacy Selke; Anna Wald
Journal:  J Med Virol       Date:  2005-07       Impact factor: 2.327

9.  Molecular identification of bacteria associated with bacterial vaginosis.

Authors:  David N Fredricks; Tina L Fiedler; Jeanne M Marrazzo
Journal:  N Engl J Med       Date:  2005-11-03       Impact factor: 91.245

10.  The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions.

Authors:  Arsenio Spinillo; Francesca Zara; Barbara Gardella; Eleonora Preti; Roberta Mainini; Renato Maserati
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

View more
  38 in total

1.  Association of Bacterial vaginosis and other Sexually Transmitted Infections with HIV among pregnant women in Nigeria.

Authors:  Godwin E Imade; Jonah Musa; Atiene S Sagay; Saidi H Kapiga; Jean-Louis Sankale; John Idoko; Phyllis Kanki
Journal:  Afr J Med Med Sci       Date:  2014-09

Review 2.  Vaginal microbiota and susceptibility to HIV.

Authors:  McKenna C Eastment; R Scott McClelland
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

3.  Mageeibacillus indolicus gen. nov., sp. nov.: a novel bacterium isolated from the female genital tract.

Authors:  Michele N Austin; Lorna K Rabe; Sujatha Srinivasan; David N Fredricks; Harold C Wiesenfeld; Sharon L Hillier
Journal:  Anaerobe       Date:  2014-12-04       Impact factor: 3.331

4.  Accurate measurement of female genital tract fluid dilution in cervicovaginal lavage samples.

Authors:  Scott A Churchman; John A Moss; Marc M Baum
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-03-02       Impact factor: 3.205

Review 5.  Research gaps in defining the biological link between HIV risk and hormonal contraception.

Authors:  Kerry Murphy; Susan C Irvin; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2014-02-19       Impact factor: 3.886

Review 6.  Mucosal correlates of protection in HIV-1-exposed sero-negative persons.

Authors:  Ruizhong Shen; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-01-16       Impact factor: 3.886

7.  Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women.

Authors:  Marla J Keller; Aileen P McGinn; Yungtai Lo; Ashley Huber; Lilia Espinoza; Howard Minkoff; Christine Colie; Marek J Nowicki; Gypsyamber D'Souza; Kathryn Anastos
Journal:  Am J Reprod Immunol       Date:  2016-05-05       Impact factor: 3.886

8.  Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women.

Authors:  Hanneke Borgdorff; Evgeni Tsivtsivadze; Rita Verhelst; Massimo Marzorati; Suzanne Jurriaans; Gilles F Ndayisaba; Frank H Schuren; Janneke H H M van de Wijgert
Journal:  ISME J       Date:  2014-03-06       Impact factor: 10.302

9.  Human α-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus.

Authors:  Gregory T Spear; Audrey L French; Douglas Gilbert; M Reza Zariffard; Paria Mirmonsef; Thomas H Sullivan; William W Spear; Alan Landay; Sandra Micci; Byung-Hoo Lee; Bruce R Hamaker
Journal:  J Infect Dis       Date:  2014-04-15       Impact factor: 5.226

10.  HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.

Authors:  Marta E Bull; Jillian Legard; Kenneth Tapia; Bess Sorensen; Susan E Cohn; Rochelle Garcia; Sarah E Holte; Robert W Coombs; Jane E Hitti
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.